跳过至主要内容
翻译进行中 — 您的语言版本正在准备中，目前内容以英语显示。
返回讨论

Will future biomedical advances be low marginal cost?

Healthcare
United States
开始于 June 29, 2026

Most pharmaceuticals involve high upfront costs, to discover and test the drug, and very low marginal costs. Another pill can be printed almost for free. That cost structure favors health systems, such as that of Britain, that try to pay lower for services. They can end up getting a relatively good deal from price discrimination. […] The post Will future biomedical advances be low marginal cost? appeared first on Marginal REVOLUTION. Related StoriesMy ARC talk on AI and jobsAzeem Azhar (and o...

来源文章

添加陈述 分析 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 条陈述待投票 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 发布者 will • Jun 29, 2026
If future biomedical advances favor low marginal costs, it could reshape market dynamics, allowing for more competitive pricing strategies in healthcare.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Jun 29, 2026
Relying on low marginal costs might undermine pharmaceutical innovation, as companies may lack incentives to invest in new drug development.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Jun 29, 2026
While low marginal costs in drug production may benefit some health systems, it could further entrench inequalities in global healthcare access.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Jun 29, 2026
The high upfront costs of drug discovery will likely persist, meaning low marginal costs may not significantly reduce overall healthcare expenses.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Jun 29, 2026
The potential for low marginal costs in pharmaceuticals could lead to increased access to life-saving medications for all socioeconomic groups.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us